+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Eradication of Helicobacter pylori: current perspectives

Eradication of Helicobacter pylori: current perspectives

Expert Opinion on PharmacoTherapy 3(8): 1031-1038

Helicobacter pylori appears to be a necessary cofactor for the majority of non-drug-associated duodenal and gastric ulcers. H. pylori infection is a chronic and transmissible infectious disease whose eradication has proved difficult. The last decade has seen > 1000 clinical trials using different eradication regimens. Many of these trials had severe limitations, some of which will be discussed here. The current review also focuses on the regimens that were used in the past, the present regimens and possibilities for the future. Also highlighted are some other aspects of H. pylori management, such as eradication failures and drug resistance.

(PDF emailed within 0-6 h: $19.90)

Accession: 045983759

Download citation: RISBibTeXText

PMID: 12150683

DOI: 10.1517/14656566.3.8.1031

Related references

Gastrointestinal Diseases in the Era without Helicobacter pylori infection. Topics: II. Present Status of Helicobacter pylori Eradication Therapy and Problems after Eradication. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 106(1): 16-22, 2017

Challenges to the Treatment and New Perspectives for the Eradication of Helicobacter pylori. Digestive Diseases and Sciences 60(10): 2901-2912, 2015

Current Helicobacter pylori eradication regimens. Acta Endoscopica 28(3): 205-212, 1998

Helicobacter pylori eradication: current status. Terapevticheskii Arkhiv 85(2): 73-75, 2013

Does eradication of Helicobacter pylori reduce the risk of carcinogenesis in the residual stomach after gastrectomy for early gastric cancer? Comparison of mucosal lesions in the residual stomach before and after Helicobacter pylori eradication. Langenbeck's Archives of Surgery 389(2): 83-91, 2004

Efficacy of two different Helicobacter pylori eradication regimens in patients with type 2 diabetes and the effect of Helicobacter pylori eradication on dyspeptic symptoms in patients with diabetes: a randomized controlled study. American Journal of the Medical Sciences 338(6): 459-464, 2010

Current indications for Helicobacter pylori eradication therapy. Scandinavian Journal of Gastroenterology. Supplement 215: 70-73, 1996

Current views on Helicobacter pylori eradication therapy. Irish Medical Journal 91(1): 8-10, 1998

Current Status of the Third-Line Helicobacter pylori Eradication. Gastroenterology Research and Practice 2018: 6523653, 2018

What is the current role of clarithromycin in the eradication of Helicobacter pylori?. Revista Espanola de Enfermedades Digestivas 89(4): 305-312, 1997

Helicobacter pylori Eradication Therapy: Current Availabilities. Isrn Gastroenterology 2012: 186734, 2012

Helicobacter pylori and non-Helicobacter pylori bacterial flora before and after eradication therapy of Helicobacter pylori. Gut 37(SUPPL 1): A14, 1995

Vonoprazan, a Novel Potassium-Competitive Acid Blocker, Should Be Used for the Helicobacter pylori Eradication Therapy as First Choice: A Large Sample Study of Vonoprazan in Real World Compared with Our Randomized Control Trial Using Second-Generation Proton Pump Inhibitors for Helicobacter pylori Eradication Therapy. Digestion 97(3): 212-218, 2018

Risks and benefits of Helicobacter pylori eradication: current status. Canadian Journal of Gastroenterology 16(1): 57-62, 2002

Pariet in current patterns of eradication of Helicobacter pylori infection. Voenno-Meditsinskii Zhurnal 322(4): 54-58, 2001